Synthetic Drug Assessment: Amphetamine and New Psychoactive Substances
$18.00 | CEU Hours:6.00 | Intermediate
CEU Course Description
Given the fast-paced nature of the New Psychoactive Substances (NPS) market, there is a continued need for analysis of the scope and magnitude of the global synthetic drugs problem based on forensic and scientific data and qualitative information. This CEU course aims to provide an improved understanding of the problem based on scientific evidence and experiences that show the complex interplay between the demand for and the supply of Amphetamine-Type Stimulants (ATS) in different contexts.
Article Author: Angela Me, Chief of the Research and Trend Analysis Branch, et al.
Exam writer: Patricia Hocking-Walker, M.S. (Psychology)
CEU Course Objectives
1. Discuss the primary precursor chemical used in the manufacture of amphetamine and methamphetamine.
2. Investigate what the risk of ATS manufacture has been heightened by.
3. Examine why NPS is a phenomenon that is difficult to detect.
4. Identify where methamphetamine manufacturing may be intended to supply the large domestic market.
5. Provide the location from where most ketamine seized in countries world-wide is perceived to originate.
6. Describe what is responsible for a rising domestic availability of methamphetamine in the United States.
Course Development: Each course is identified and reviewed by the appropriate Quantum Units Education consultant with professional and licensed expertise in the various disciplines we serve. Our professional consultants oversee course development to satisfy the needs of various professionals based on their board requirements, rate course degree of difficulty and ensure the course content and exam questions are appropriate, relevant and comprehensive. See our professional staff and their bios here.
*Board Approvals for this course can be found here.
*Questions regarding how to take a course, refunds, grievance policy and ADA policy can be found here.
*Questions regarding this course or need support? Contact us at: email@example.com.